³í¹®) Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial ¼¿ï´ëº´¿ø ½ÉÇ÷°ü¼¾ÅÍ ±èÈ¿¼ö·¹Ú°æ¿ì·°ÁöÈÆ ±³¼öÆÀ